A multicentre, randomized, open label, parallel group pilot study comparing efficacy and safety of sufentanil transdermal delivery system (TDS) to oral sustained release morphine sulphate in patients with chronic cancer pain.

Trial Profile

A multicentre, randomized, open label, parallel group pilot study comparing efficacy and safety of sufentanil transdermal delivery system (TDS) to oral sustained release morphine sulphate in patients with chronic cancer pain.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Mar 2017

At a glance

  • Drugs Morphine (Primary) ; Sufentanil (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors hameln rds
  • Most Recent Events

    • 09 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top